Analyst firms · Barclays · LEN

Barclays LEN price target and rating history

Lennar Corporation (LEN) · Consumer Discretionary

Barclays rates Lennar Corporation (LEN) Underweight with a $98 price target, as of its latest action on Dec 8, 2025. It has published 4 rating actions on LEN since December 2021, including 1 upgrade and 2 downgrades. Across 11 firms with a LEN price target in the last 12 months, the median target is $95. Barclays's $98 is 3% above that.

Current rating
Underweight
Price target
$98
Median target, all firms
$95
Actions on LEN
4

Barclays price target on LEN

$181$140$9820222023202420252026
Barclays price target on LEN, each point a stated target, December 2021 to December 2025.

Every Barclays rating on LEN

How other firms rate LEN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
MeliusSell$72Oct 6, 2026
Morgan StanleyUnderweight$65Oct 1, 2026
Keefe, Bruyette & WoodsUnderperform$86Jun 9, 2026
Seaport Research PartnersSell$74Apr 7, 2026
Truist SecuritiesHold$110Mar 4, 2026
Citizens JMPMkt PerformJan 7, 2026
UBSNeutral$122Jan 6, 2026
RBC Capital MarketsUnderperform$95Dec 18, 2025
Evercore ISIUnderperform$92Dec 18, 2025
BofA SecuritiesUnderperform$95Dec 18, 2025
BarclaysUnderweight$98Dec 8, 2025
BTIGSell$96Dec 2, 2025

Questions about Barclays and LEN

What is Barclays's price target for LEN?
Barclays's latest stated price target for Lennar Corporation (LEN) is $98, from its action on Dec 8, 2025.
What is Barclays's rating on LEN?
Barclays rates LEN Underweight, a bearish rating, as of Dec 8, 2025.
When did Barclays last change its view on LEN?
On Dec 8, 2025, Barclays downgrades to Underweight from Equal Weight, price target $98.
How does Barclays's LEN target compare with other analysts?
Across 11 firms with a LEN price target in the last 12 months, the median target is $95. Barclays's $98 is 3% above that.

More LEN rating histories

All Barclays ratingsLEN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.